Skip to content
Evigrade
CriticalAntiepileptics. Carboxamide derivatives×Antianginal – late sodium current inhibitor

Updated · Methodology

Mechanism

The liver breaks down ranolazine mainly through the enzyme CYP3A4 and to a lesser extent through CYP2D6. Ranolazine is also a substrate of the transporter P-glycoprotein (ranolazine label, US Food and Drug Administration, FDA). Carbamazepine strongly induces CYP3A4 and other liver enzymes, so it can lower the levels of drugs cleared mainly through CYP3A4 (carbamazepine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). CYP3A4 inducers are expected to make ranolazine ineffective. Rifampicin 600 mg daily lowers ranolazine levels by about 95%, and the ranolazine documents name carbamazepine among these inducers (ranolazine SmPC, European Medicines Agency, EMA, and ranolazine label, FDA). The documents give no figures for carbamazepine itself.

Symptoms

Ranolazine is given to adults with stable angina as an add-on when first-line antianginal drugs do not control symptoms or are not tolerated (ranolazine summary of product characteristics, SmPC, European Medicines Agency, EMA). With carbamazepine, ranolazine is expected to lose its effect (ranolazine SmPC, EMA), so angina attacks (pressing pain behind the breastbone on exertion) may come back or become more frequent. The fall in ranolazine levels itself causes no symptoms. Stopping carbamazepine abruptly can trigger epileptic seizures (carbamazepine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS).

Management

The combination is contraindicated: ranolazine must not be taken with CYP3A inducers, and the US label names carbamazepine among them (ranolazine label, US Food and Drug Administration, FDA). The European ranolazine summary of product characteristics (SmPC) says not to use ranolazine in patients taking CYP3A4 inducers, carbamazepine among them, and not to start ranolazine during treatment with them (ranolazine SmPC, European Medicines Agency, EMA). Tell the patient that ranolazine must not be taken with carbamazepine or other such drugs (ranolazine FDA label). The carbamazepine SmPC does not mention ranolazine. According to it, carbamazepine strongly induces CYP3A4 and can lower the levels of drugs cleared mainly through this enzyme, or even cancel their effect (carbamazepine SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Do not stop carbamazepine abruptly: the SmPC says to withdraw it gradually over 6 months (carbamazepine SmPC, AEMPS). The documents give no interval between stopping carbamazepine and starting ranolazine.

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Carbamazepine

Other interactions with Ranolazine